Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

PARTIALLY ADDRESSED

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflammasome activation and neuronal apoptosis. Contribution of lysosomal dysfunction upstream of Abeta/tau pathology and therapeutic strategies to restore lysosomal function need investigation.

Priority: 0.82 Domain: neuroscience Hypotheses: 13
📊 Landscape Analysis

Landscape Summary: Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression is a 0.82 priority gap in neuroscience. It has 13 linked hypotheses with average composite score 0.699. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression — INVOKE-2 (completed)

📈 Living Dashboards
13
Hypotheses
0.924
Top Score
0.699
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurode
Target: NLRP3, CASP1, IL1B, PYCARD Pathway: Gut-brain axis TLR4/NF-κB prim
0.924
score
Closed-loop transcranial focused ultrasound to restore hippocampal gam
Target: PVALB Pathway: Gamma oscillation generation v
0.865
score
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein A
Target: NLRP3, CASP1, IL1B, PYCARD Pathway: Astrocyte NLRP3 inflammasome a
0.822
score
Lysosomal Positioning Dynamics Modulation
Target: LAMP1 Pathway: Lysosomal membrane / lysosomal
0.686
score
Microbial Inflammasome Priming Prevention
Target: NLRP3, CASP1, IL1B, PYCARD Pathway: NLRP3 inflammasome activation
0.653
score
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Target: TFEB Pathway: TFEB-mediated lysosomal biogen
0.652
score
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Target: NURR1, PITX3, neuronal identity transcription factors Pathway: CRISPRa epigenetic activation
0.630
score
Multi-Modal CRISPR Platform for Simultaneous Editing and Monitoring
Target: Disease-causing mutations with integrated reporters Pathway: Multiplexed CRISPR editing wit
0.629
score
Cardiovascular-Neuroinflammation Crosstalk Interruption
Target: IL1B, TNFA, NLRP3 Pathway: NLRP3 inflammasome activation
0.587
score
Lysosomal Membrane Repair Enhancement
Target: CHMP2B Pathway: Lysosomal function / degradati
0.538
score
🌊 Knowledge Graph Connections

activates (17)

AlzheimerOxidative StressAlzheimerApoptosisAlzheimerMtorAlzheimerMitophagyGENESAlzheimer
▸ Show 12 more

associated with (8)

TauopathyAlzheimerAlzheimerAutophagyDiabetesAlzheimerDNAAlzheimerAlzheimerSenescence
▸ Show 3 more

biomarker for (2)

GFAPAlzheimerNFLAlzheimer

expressed in (3)

APOEAlzheimerAPOE4AlzheimerTREM2Alzheimer

regulates (8)

APPAlzheimerAlzheimerOxidative StressDNAAlzheimerAKTAlzheimerAlzheimerLipid Metabolism
▸ Show 3 more

therapeutic target (12)

AlzheimerApoptosisAlzheimerLipid MetabolismDNAAlzheimerAlzheimerImmune ResponseAlzheimerBlood-Brain Barrier
▸ Show 7 more
🕑 Activity Feed
📈 Microbial Inflammasome Priming Prevention score=0.653 2026-04-02T07:45
📈 Lysosomal Positioning Dynamics Modulation score=0.686 2026-04-02T01:34
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps